Biophytis Targets Mobility Restoration in Patients with Obesity @biophytis #biotech #GLP1 #muscle #obesity #weightloss #Chemicals #Biotechnology #OTC #OTCMarkets #OTCStocks #Investing

Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - April 22, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in developing treatments for age-related diseases strentghens its position as one of the leading players in preserving muscle function in patients with obesity treated with GLP-1 therapies. While these treatments are revolutionizing obesity care by delivering significant weight loss, they also induce a...


http://dlvr.it/TKHyMR

Comments

Popular posts from this blog

SEC Investor Advisory Committee to Discuss Exempt Offerings and Accredited Investors at September 21 Meeting #Banking #FinancialServices

Cleantek Industries Inc. Announces a Twelve-Month Extension of Credit Facility #CTEK.CA #CTEK.V #GLKFF #Investing #OTC #OTCMarkets #OTCStocks #SmallCaps #TSXV #Technology

International Property Alerts: Global Property Exhibition Singapore 2025 Highlights London's Best New Developments #Advertising